Free tool
FAERS Monitor: Ritalin
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 010187 or its brand name (Ritalin, Methylphenidate Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
24,249
Serious
14,895
61% of reports
Hospitalization
5,209
Death reported
1,137
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective2,492
- fatigue1,726
- nausea1,471
- headache1,395
- anxiety1,352
- depression1,172
- somnolence989
- off label use951
- insomnia937
- feeling abnormal904
- dizziness852
- weight decreased795
- vomiting765
- pain761
- suicidal ideation716
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 400 |
| 2005 | 420 |
| 2006 | 407 |
| 2007 | 386 |
| 2008 | 401 |
| 2009 | 443 |
| 2010 | 512 |
| 2011 | 572 |
| 2012 | 699 |
| 2013 | 647 |
| 2014 | 797 |
| 2015 | 1,779 |
| 2016 | 3,218 |
| 2017 | 1,771 |
| 2018 | 1,815 |
| 2019 | 1,649 |
| 2020 | 1,277 |
| 2021 | 961 |
| 2022 | 1,203 |
| 2023 | 1,385 |
| 2024 | 1,288 |
| 2025 | 1,263 |
| 2026 | 955 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,029,910 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| suicidal ideationSignal | 716 | 6.8 | 6.4 | 3,545 |
| depressionSignal | 1,172 | 4.5 | 4.2 | 3,189 |
| somnolenceSignal | 989 | 4.3 | 4.0 | 2,491 |
| anxietySignal | 1,352 | 4.1 | 3.9 | 3,240 |
| feeling abnormalSignal | 904 | 3.3 | 3.1 | 1,442 |
| insomniaSignal | 937 | 3.1 | 2.9 | 1,308 |
| weight decreasedSignal | 795 | 2.5 | 2.3 | 704 |
| headache | 1,395 | 1.9 | 1.8 | 644 |
| fatigue | 1,726 | 1.9 | 1.8 | 794 |
| drug ineffective | 2,492 | 1.6 | 1.6 | 664 |
| nausea | 1,471 | 1.6 | 1.5 | 355 |
| dizziness | 852 | 1.5 | 1.4 | 136 |
| vomiting | 765 | 1.4 | 1.3 | 93 |
| pain | 761 | 1.1 | 1.0 | 4 |
| off label use | 951 | 0.9 | 0.9 | 3 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.